Biotech entity
Of the tracked stories, 1 of 2 also mention American Association for Cancer Research (AACR), the most common co-covered peer. That works out to roughly 0.8 stories per week across a 17-day span. Coverage clusters in clinical-trial, which accounts for 1 of those 2, with the remainder spread across 1 other category.
Last mentioned: Jul 15, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention American Association for Cancer Research (AACR), the most common co-covered peer. That works out to roughly 0.8 stories per week across a 17-day span. Coverage clusters in clinical-trial, which accounts for 1 of those 2, with the remainder spread across 1 other category. They are less corroborated than the beat average, carrying 5.5 original sources each against 5.6 for the same window. At 6.5, the average consequence score sits below the same-window beat average of 6.7. National Institutes of Health (NIH) appears in 2 tracked Biotech stories published from July 15, 2026 through July 31, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 79 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering National Institutes of Health (NIH). Shared-story counts are live from our verified record — not editorial picks.
AACR Report Released
The American Association for Cancer Research publishes its report on cancer disparities research disruption, revealing 93% of surveyed researchers affected.
Senators react
Sens. Rand Paul and Ron Johnson publicly call for legal challenges to the pardon, state-level prosecution, and full investigations into Fauci’s actions.
Gabbard releases intelligence files
Outgoing DNI Tulsi Gabbard declassifies and releases trove of documents alleging Fauci’s deception and funding of Wuhan gain-of-function research.
JAMA Oncology Publication
A study in JAMA Oncology details the cancellation of 181 NCI grants, bringing the issue to wider academic attention.
NCI Cancels 181 Grants
In the first half of 2025, the National Cancer Institute cancels 181 grants worth over $317 million, many focused on cancer disparities research.
Executive Order on Federal Grants
The Trump administration issues an executive order enabling freezes and cancellations of scientific research grants, particularly those related to diversity and equity.
Preemptive pardon granted
President Biden issues a preemptive pardon to Fauci before leaving office, covering potential federal crimes related to the pandemic.
Fauci testifies to Congress
Fauci testifies that he had no contact with intelligence agencies regarding viral research, a claim now contradicted by Gabbard's files.
Outgoing DNI Tulsi Gabbard’s intelligence release alleges Dr. Anthony Fauci directed millions in taxpayer dollars to fund dangerous bat coronavirus research at the Wuhan lab, threatening public trust and likely triggering a regulatory crackdown on gain-of-function studies across the biotech sector.
Source: fox11online.com · ktul.com
The cancellation of 181 NCI grants totaling $317 million in early 2025 has stopped cancer disparity clinical trials in their tracks, according to an AACR report. The biotech and pharma pipelines face disruption as critical early-stage research evaporates.
Source: houstonpublicmedia.org · wyomingpublicmedia.org
National Institutes of Health (NIH) is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
